Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01897363 · ClinicalTrials.gov registry record
Hypoglycemia in Prader-Willi Syndrome
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 2
- Enrollment target
NCT01897363: Completed study, sponsored by University of Florida.
NCT01897363 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01897363 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 2 participants
- Enrollment target
Study Summary
This project will study whether infants with Prader-Willi Syndrome experience low blood sugars after short periods of fasting. This study will also evaluate metabolic markers in the blood to determine if infants with Prader-Willi Syndrome process energy differently than other children during fasting.
Primary Outcome
We will determine whether fasting occurs within 6 hours of fasting in infants with Prader-Willi Syndrome
Interventions
- OTHER Infants with Prader-Willi Syndrome
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-09 |
What the finished NCT01897363 record still lists
NCT01897363 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Infants with Prader-Willi Syndrome is the first listed.
NCT01897363 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01897363 about?
NCT01897363 is a clinical study titled "Hypoglycemia in Prader-Willi Syndrome". This project will study whether infants with Prader-Willi Syndrome experience low blood sugars after short periods of fasting. This study will also evaluate metabolic markers in the blood to determine if infants with Prader-Willi Syndrome process energy differently than other children during fasting...
What is the current status of trial NCT01897363?
This trial is currently completed. The enrollment target is 2 participants. The study started on 2013-07. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01897363?
The interventions under investigation include: Infants with Prader-Willi Syndrome (OTHER).
Who is sponsoring clinical trial NCT01897363?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia